Pilot open trial of efficacy of Risperidone in Delusional Parasitosis

Phase 1

• Conditions: Delusional Parasitosis; MedDRA version: 9.1 Level: LLT Classification code 10012242 Term: Delusion of parasitosis

• Registration Number: EUCTR2006-007019-25-GB
• Lead Sponsor: Barts and the London NHS Trust

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2007-04-17
• Study Completion: 2009-03-01
• Last Update Posted: 28 February 2019

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

Patients will be recruited from the joint Psychodermatology Clinic to which patients are referred from the North East London area.

Patients with a diagnosis of delusional parasitosis made by the consultant dermatologist and psychiatrist doing the clinic.

Patients will be categorised according to whether there may be another psychiatric diagnosis e.g., depressive disorder, drug abuse, dementia or schizophrenia. However, they will still be left in the trial.

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Patients under 18 years;
patients incapable of giving informed consent;
pregnancy or lactation;
a history of an adverse reaction to atypical neuroleptics

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified